Showing results (161-170 of 1,109) with videos related to
Sort By:
Pageof 111
Mutagenesis|July 1, 1989
Co-administration of ascorbic acid with cyclophosphamide (CPA) to pregnant mice inhibits the clastogenic activity of CPA in preimplantation murine blastocystsI Kola, R Vogel, H SpielmannWater Environment Research : a Research Publication of the Water Environment Federation|September 14, 2016
Urban Stormwater Characterization, Control, and TreatmentJason R Vogel, Trisha L MooreQuality Management in Health Care|October 28, 1999
The clinical research triad: how can we ensure quality in out-sourced clinical trials?L G Strause, J R VogelReceptors & Channels|August 22, 2000
Bacterial expression of G-protein-coupled receptors: prediction of expression levels from sequenceH Kiefer, R Vogel, K MaierPharmacology, Biochemistry, and Behavior|March 1, 1975
Learned taste aversions induced by hypnotic drugsJ R Vogel, B A NathanArchives of Ophthalmology (Chicago, Ill. : 1960)|August 1, 1995
A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study GroupE Strahlman, R Tipping, R VogelAmerican Journal of Ophthalmology|August 1, 1996
A six-week dose-response study of the ocular hypotensive effect of dorzolamide with a one-year extension. Dorzolamide Dose-Response Study GroupE Strahlman, R Tipping, R VogelThe American Journal of Cardiology|January 1, 1978
Abnormal platelet survival time in men with myocardial infarction and normal coronary arteriogramP Steele, J Rainwater, R VogelChest|November 1, 1981
Effect of platelet suppressant treatment with dipyridamole and aspirin on exercise performance and platelet survival time in coronary diseaseP Steele, J Rainwater, R VogelBritish Journal of Pharmacology|January 1, 1982
Uptake of 6-fluoro-5-hydroxytryptamine and 4,6-difluoro-5-hydroxytryptamine into releasable and non-releasable compartments of human plateletsJ L Costa, K L Kirk, H StarkPageof 111